New study tests workplace coaching to keep Parkinson's patients on the job

NCT ID NCT06573866

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tests a personalized workplace intervention for 124 Dutch workers with Parkinson's disease, cerebellar ataxia, hereditary spastic paraparesis, or slowly progressive neuromuscular/mitochondrial disorders. A trained facilitator helps employees and their managers identify work obstacles and find practical solutions. The goal is to reduce fatigue after work and improve job retention over 18 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Preventive Participatory Workplace Intervention (PPWI) – a structured process where a facilitator helps employees and managers identify and solve work-related obstacles.

What this could lead to

If successful, this could provide a practical, low-cost way to help people with progressive movement disorders keep working longer and improve their quality of life.

What could go wrong

This is a relatively small, single-country trial testing a behavioral intervention, so results may not apply broadly. The intervention depends on employer cooperation, which may vary.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CEREBELLAR ATAXIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cerebellar ataxia hereditary spastic paraplegia inborn mitochondrial metabolism disorder mitochondrial disease neurodegenerative disease neuromuscular disease Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Radboudumc

    Nijmegen, Gelderland, 6525 GA, Netherlands